v3.26.1
Net Loss Per Class A Common Share Attributable to Maravai LifeSciences Holdings, Inc. - Summary of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]        
Net loss $ (21,631) $ (69,837) $ (28,008) $ (122,690)
Less: loss attributable to common non-controlling interests 9,215 30,246 11,859 53,154
Net loss attributable to Maravai LifeSciences Holdings, Inc., basic (12,416) (39,591) (16,149) (69,536)
Net loss attributable to Maravai LifeSciences Holdings, Inc., diluted $ (12,416) $ (39,591) $ (16,149) $ (69,536)
Weighted average Class A common shares outstanding - basic (in shares) 147,996 144,236 147,215 143,833
Weighted average Class A common shares outstanding - diluted (in shares) 147,996 144,236 147,215 143,833
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., basic (in usd per share) $ (0.08) $ (0.27) $ (0.11) $ (0.48)
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., diluted (in usd per share) $ (0.08) $ (0.27) $ (0.11) $ (0.48)